Pertussis Vaccine — An Analysis of Benefits, Risks and Costs

New England Journal of Medicine

Volumn 301, Issue 17, 1979, Pages 906-911

  Koplan, Jeffrey P ^a,b,c   Schoenbaum, Stephen C ^a,b,c   Weinstein, Milton C ^a,b,c   Fraser, David W ^a,b,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

ADVERSE DRUG REACTION; CENTRAL NERVOUS SYSTEM; COST BENEFIT ANALYSIS; ENCEPHALITIS; EPIDEMIOLOGY; FEVER; MALAISE; PERTUSSIS; PREVENTION; PREVENTIVE MEDICINE; RESPIRATORY SYSTEM; RISK FACTOR;

EID: 0018635592     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197910253011703     Document Type: Article

References (22)

1. Bassili WR, Stewart GT: Epidemiological evaluation of immunisation and other factors in the control of whooping-cough. Lancet 1: 471–474, 1976
2. Stewart GT: Vaccination against whooping-cough: efficacy versus risks. Lancet 1: 234–237, 1977
3. Health chiefs cut short warning against vaccine. Sunday Times, Jan. 9, 1977
4. Raiffa H: Decision Analysis: Introductory lectures on choices under uncertainty. Reading, Massachusetts, Addison-Wesley, 1968
5. American Academy of Pediatrics: Report of the Committee on Infectious Diseases. Eighteenth edition. Evanston, Illinois, 1977
6. Sako W, Treuting WL, Witt DB, et al: Early immunization against pertussis with alum precipitated vaccine. JAMA 127: 379–384, 1945
7. Miller CL, Pollock TM, Clewer ADE: Whooping-cough vaccination: an assessment. Lancet 2: 510–513, 1974
8. Ström J: Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959–65. Br Med J 4: 320–323, 1967
9. Center for Disease Control: Follow-up on DTP vaccination in sudden infant deaths — Tennessee. Morbid Mortal Weekly Rep 28: 134–135, 1979
10. Lambert HJ: Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep 80: 365–369, 1965
11. Gordon JE, Hood RI: Whooping cough and its epidemiological anomalies. Am J Med Sci 222: 333–361, 1951
12. Miller CL, Fletcher WB: Severity of notified whooping cough. Br Med J 1: 117–119, 1976
13. Brooksaler F, Nelson JD: Pertussis: a reappraisal and report of 190 confirmed cases. Am J Dis Child 114: 389–396, 1967
14. Stangert K: Clinical course and prognosis of whooping-cough in Swedish children during the first six months of life. Scand J Infect Dis 2: 45–48, 1970
15. Miller H: Discussion on the neurological complications of the acute specific fevers. Proc R Soc Med 49: 139–146, 1956
16. American Medical Association: The Profile of Medical Practice. Chicago, 1977
17. Hauge J: Hospital indicators: 1977–1978 comparisons show little changes. Hospitals 52(16): 53–56, 1978
18. Cooper BS, Rice DP: The Economic Cost of Illness Revisited (DHEW Publication No. [SSA] 76–11703). Washington, DC, Government Printing Office, 1976, pp 21–36
19. Church MA: Evidence of whooping-cough vaccine efficacy from the 1978 whooping-cough epidemic in Hertfordshire. Lancet 2: 188–190, 1979
20. Kurt TL, Yeager AS, Guenette S, et al: Spread of pertussis by hospital staff. JAMA 221: 264–267, 1972
21. Linnemann CC Jr, Ramundo N, Perlstein PH, et al: Use of pertussis vaccine in an epidemic involving hospital staff. Lancet 2: 540–543, 1975
22. Voorhoeve AM, Muller AS, Schulpen TWJ, et al: Machakos project studies: agents affecting health of mother and child in a rural area of Kenya. IV. The epidemiology of pertussis. Trop Geogr Med 30: 125–139, 1978